¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ¹× ¿¬¼ö°­Á : 2023-04-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

 

 

´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ¹× ¿¬¼ö°­Á : 2023-04-02
±³À°ÀÏÀÚ : 2023-04-02
±³À°Àå¼Ò : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ¹× ¿¬¼ö°­Á °³ÃÖ
±³À°ÁÖÁ¦ : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ¹× ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
´ã´çÀÚ : ¿À¼ºÈñ
¿¬¶ôó : 02-777-9896
À̸ÞÀÏ : work@koreanosteoporosis.or.kr
±³À°Á¾·ù : ³»°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаúÀÇ»çÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÁ¤Ã¥, º¸Çè, ±âŸ
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°­·á : 90,000¿ø
ºñ°í »çÀüµî·Ï :

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 09:00~09:20 Current strategies to treat sarcopenia Á¶¹ÎÁØ(¼­¿ïÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 09:20~09:40 Basic research in muscle regeneration °ø¿µÀ±(¼­¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 09:40~10:00 Muscle regeneration and aging °­Á¾¼ø(¼º±Õ°üÀÇ´ë)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 10:00~10:15 Q&A ()
ÈÞ½Ä 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 10:15~10:35 coffee break ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 10:35~10:55 Update on the trabecular bone score in osteoporosis ÃÖ¿ëÁØ(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 10:55~11:15 Update on the quantitative CT in osteoporosis ±è°æ¹Î(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 11:15~11:35 Accuracy and performances of the 2D to 3D-DXA mapping procedure using 3D-SHAPER¢ç Luca Quagliato(ÀÌÈ­¿©´ë ÈÞ¸Õ±â°è¹ÙÀÌ¿À°øÇкÎ)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 11:35~11:50 Q&A ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 11:50~12:10 How to Forging Path Forward for Strengthening Bone Health ±è¼º¼ö(ÀÎÁ¦ÀÇ´ë Á¤Çü¿Ü°ú)
½Ä»ç 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 12:10~13:00 Á¡½É½Ã°£ ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 13:00~13:20 Discontinuing denosumab: Can it be done safely? ±èâÇö(¼øõÇâÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 13:20~13:40 Zoledronate: ´Ù¾çÇÑ ÀÓ»óÀû¿ëÀÇ ½ÇÁ¦ ¹ÚÀç¹Î(¿¬¼¼ÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 13:40~14:00 Recent issues for ONJ ¹ÚÁÖ¿µ(¼­¿ïÄ¡´ë ±¸°­¾Ç¾È¸é¿Ü°ú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 14:00~14:15 Q&A ()
ÈÞ½Ä 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 14:15~14:35 coffee break ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 14:35~14:55 Recent Update on the Safety and Efficacy: Teriparaitde vs. abaloparatide ±è»ó¹Î(°í·ÁÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 14:55~15:15 Modeling Based vs. Remodeling Based Bone Formation: What are the differences? °­°æÁß(°æÈñÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 15:15~15:35 Romososumab: ÀÓ»óÀû¿ëÀÇ ½ÇÁ¦ ÀÌȯÈñ(°¡Å縯ÀÇ´ë Á¤Çü¿Ü°ú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 15:35~15:45 Q&A ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 15:45~16:05 Recent Update on the Safety and Efficacy: Teriparaitde vs. abaloparatide ±è»ó¹Î(°í·ÁÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 16:05~16:25 Modeling Based vs. Remodeling Based Bone Formation: What are the differences? °­°æÁß(°æÈñÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 16:25~16:45 Romososumab: ÀÓ»óÀû¿ëÀÇ ½ÇÁ¦ ÀÌȯÈñ(°¡Å縯ÀÇ´ë Á¤Çü¿Ü°ú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó1·ë 16:45~16:55 Q&A ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 09:00~09:20 °ñ´ë»ç ±âÃÊ ½±°Ô ÀÌÇØÇϱâ ÃÖÇѼ®(µ¿±¹ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 09:20~09:40 °ñ´Ù°øÁõ Áø´Ü ¹× Æò°¡ÀÇ pitfall ±èöȣ(¿ï»êÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 09:40~10:00 Ç÷¾×°Ë»ç È°¿ë°ú ÃßÀû°üÂû ±æ¶óÀâÀÌ ÇÑ°ÇÈñ(¼­¿ïÀÇ·á¿ø °¡Á¤ÀÇÇаú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 10:00~10:15 Q&A ()
ÈÞ½Ä 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 10:15~10:35 Coffee break ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 10:35~10:55 ´Ù¾çÇÑ Ca & Vit. D ¿Ã¹Ù¸£°Ô ¼±ÅÃÇϱ⠱迵»ó(Â÷ÀÇ°úÇÐ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 10:55~11:15 ³»°úÀû Áúȯ¿¡ µû¸¥ °ñ´Ù°øÁõ ¾àÁ¦¼±Åà ÀÓÁ¤¼ö(¿¬¼¼¿øÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 11:15~11:35 ±Ù°¨¼ÒÁõ ¹× °ñ´Ù°øÁõ ȯÀÚÀÇ »ýÈ°½À°ü °ü¸® ±è¿ëȯ(ÃæºÏÀÇ´ë °¡Á¤ÀÇÇаú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 11:35~11:50 Q&A ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 11:50~12:10 Expanded Usage of Zoledronic Acid À̵¿¿Á(±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 13:00~13:20 SERM & MHT (Menopausal Hormone Therapy) ±è¼º¿ì(¼­¿ïÀÇ´ë »êºÎÀΰú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 13:20~13:40 Bisphosphonate & Denosumab ¾ÈűÙ(Â÷ÀÇ°úÇдë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 13:40~14:00 Romosozumab & Teriparatide ¹ÚÇü¿­(°¡Å縯ÀÇ´ë Á¤Çü¿Ü°ú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 14:00~14:15 Q&A ()
ÈÞ½Ä 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 14:15~14:35 Coffee break ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 14:35~14:55 ¹Ýµå½Ã ¾Ë¾Æ¾ß ÇÏ´Â °ñ´Ù°øÁõ º¸Çè±âÁØ ¾÷µ¥ÀÌÆ® À±¼®±â(õ¾È¿£µµ³»°úÀÇ¿ø)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 14:55~15:15 °ñ´Ù°øÁõ Ä¡·á ºñ¹ÝÀÀ±º¿¡ ´ëÇÑ ´ëÀÀ Àü·« ±è±¤ÁØ(¿¬¼¼ÀÇ´ë ³ë³â³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 15:15~15:35 °ñ´Ù°øÁõ ¾àÁ¦ º´ÇÕ¿ä¹ý°ú ¼øÂ÷Ä¡·á È«»ó¸ð(ÇѾçÀÇ´ë ³»ºÐºñ³»°ú)
Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 15:35~15:45 Q&A ()
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 15:45~16:05 µ¥³ë¼ö¸¿ »ç¿ë½Ã À¯ÀÇÁ¡ ¾÷µ¥ÀÌÆ® ±èÀ¯¹Ì(°¡Å縯°üµ¿ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 16:05~16:25 °ñ´Ù°øÁõ ¾àÁ¦¿Í °ñÀ¯ÇÕ ±è»óÀÏ(°¡Å縯ÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 16:25~16:45 ´ëÇк´¿ø ±¸°­¾Ç¾È¸é¿Ü°ú¿¡ ³»¿øÇÑ ONJ ȯÀÚ Ä¡·á °æÇè °øÀ¯ ±èÁØ¿µ(¿¬¼¼Ä¡´ë ±¸°­¾Ç¾È¸é¿Ü°ú)

Åä·Ð 04-02 ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÇѶó2·ë 16:45~16:55 Q&A ()

 

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ¹× ¿¬¼ö°­Á : 2023-04-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-02
´ÙÀ½±Û °æÈñ´ëÇб³º´¿ø óÀ½ ½ÃÀÛ ÇÏ´Â »ç¶÷µéÀ» À§ÇÑ 2023 °æÈñ½ÉÃÊÀ½ÆÄ ¿¬¼ö°­Á : 2023-04-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21077 ¼­¿ï ´ëÇÑÅ»ÀåÇÐȸ 18th Congress of the KHS & 2024 International Symposium(2ÀÏÂ÷) : 2024-07-06 0 34 2024-06-18
21076 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ 2024 Breast Biopsy Symposium : 2024-07-06 0 56 2024-06-18
21075 ¼­¿ï 2024³â ´ëÇѼö¸é¿¬±¸ÇÐȸ Á¤±â Çмú´ëȸ DAY 1 : 2024-07-06 0 49 2024-06-18
21074 ±¤ÁÖ 2024³âµµ ´ëÇÑÇǺΰúÀÇ»çȸ ±¤ÀüÁöºÎ ±³À°½ÉÆ÷Áö¿ò : 2024-07-06 0 85 2024-06-18
21073 ¼­¿ï (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 2 : 2024-07-06 0 61 2024-06-18
21072 ´ë±¸ 2024 ´ëÇѺñ¸¸ÇÐȸ Obesity Summer Çмú´ëȸ : 2024-07-06 0 115 2024-06-18
21071 ¼­¿ï 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06 0 79 2024-06-18
21070 ¼­¿ï ´ëÇѺҾÈÀÇÇÐȸ (¿Â¶óÀÎ) ½ºÆ®·¹½º°ü¸® ÇÁ·Î±×·¥ : 2024-07-06 0 30 2024-06-18
21069 ¼­¿ï 2024³â Á¦25ȸ ´ëÇÑÇǺΰúÇÐȸ ¿¬¼ö±³À° : Conerstone and General : 2024-07-06 0 55 2024-06-18
21068 ´ëÀü 2024 ´ëÀü¼­±¸ÀÇ»çȸ Çмú´ëȸ : 2024-07-05 0 55 2024-06-18
21067 °æºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ - Á¦3ȸ ¿¬¼ö°­Á : 2024-07-05 0 56 2024-06-18
21066 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø 125Áֳ⠱â³ä ±¹Á¦Çмú´ëȸ : 2024-07-05 0 46 2024-06-18
21065 ¼­¿ï ´ëÇÑÅ»ÀåÇÐȸ 18th Congress of the KHS & 2024 International Symposium(1ÀÏÂ÷) : 2024-07-05 0 49 2024-06-18
21064 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 1 : 2024-07-05 0 38 2024-06-18
21063 °æ³² ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦111Â÷ ¿¬¼ö±³À° : 2024-07-04 0 103 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷